Table 4 Comparison between controls and patients regarding SN-5 questionnaire

Q1

M(IQR)

3.12 ± 1.37

3(2–4)

0.57 ± 0.5

1(0–1)

12.168

< 0.00001**

Q2

M(IQR)

3.71 ± 1.30

4(3–5)

0.66 ± 0.62

1(0–1)

12.253

< 0.00001**

Q3

M(IQR)

3.34 ± 1.09

3(3–4)

0.43 ± 0.5

0(0–1)

12.841

< 0.00001**

Q4

M(IQR)

2.76 ± 1.17

3(2–3)

0.43 ± 0.5

0(0–1)

12.106

< 0.00001**

Q5

M(IQR)

2.17 ± 0.99

2(1–3)

1.07 ± 0.46

1(1–1)

8.038

< 0.00001**

Total score

M(IQR)

15.1 ± 3.97

15(12–18)

3.16 ± 1.31

3(2–4)

12.971

< 0.00001**

VAS

M(IQR)

5.38 ± 1.32

5(5–6)

8.71 ± 0.701

9(8–9)

− 12.75434.

< 0.00001**